CDEK by Data4ThePeople
Sign in Sign up
← All organizations

ORPHALAN

For profit

Also known as: Orphalan | ORPHALAN

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

First clinical trial

Jan 2, 2024

First marketed drug

Apr 28, 2022

Last known activity

Jan 2, 2024

Timeline

2020s

  1. Apr 28, 2022

    triethylenetetramine— Marketing Organization

  2. Apr 28, 2022

    triethylenetetramine— NDA Secondary Org

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (1)

Details

Last known activity
Jan 2, 2024